Fall in oxygen tension of culture medium stimulates the adenosinergic signalling of a human T cell line

Purinergic Signalling

Volumn 8, Issue 4, 2012, Pages 661-667

  By, Youlet ^a   Jacquin, Laurent ^a   Franceschi, Frédéric ^a   Durand Gorde, Josée Martine ^a   Condo, Jocelyne ^a   Michelet, Pierre ^a   Guieu, Régis ^a   Ruf, Jean ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

A2AR; Adenosine; HIF 1 ; Hypoxia; T cells

Indexed keywords

ADENOSINE; ADENOSINE A2A RECEPTOR; ADENOSINE DEAMINASE; CYCLIC AMP; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LACTIC ACID;

ARTICLE; CD4+ T LYMPHOCYTE; CELL COUNT; CELL HYPOXIA; CELL PH; CELL VIABILITY; CULTURE MEDIUM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; OXYGEN TENSION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADENOSINE; CELL HYPOXIA; CELL LINE; CULTURE MEDIA; CYCLIC AMP; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; OXYGEN; RECEPTOR, ADENOSINE A2A; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TIME FACTORS; UP-REGULATION;

EID: 84867864998     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-012-9295-6     Document Type: Article

References (32)

1. Harris AL (2002) Hypoxia-a key regulatory factor in tumour growth. Nat Rev Cancer 2: 38-47.
2. Sitkovsky MV, Ohta A (2005) The 'danger' sensors that STOP the immune response: the A2 adenosine receptors? Trends Immunol 26: 299-304.
3. Gorlach A (2005) Control of adenosine transport by hypoxia. Circ Res 97: 1-3.
4. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53: 527-552.
5. Sitkovsky M, Lukashev D (2005) Regulation of immune cells by local-tissue oxygen tension: HIF1 alpha and adenosine receptors. Nat Rev Immunol 5: 712-721.
6. Ohta A, Sitkovsky M (2009) The adenosinergic immunomodulatory drugs. Curr Opin Pharmacol 9: 501-506.
7. Kobayashi S, Zimmermann H, Millhorn DE (2000) Chronic hypoxia enhances adenosine release in rat PC12 cells by altering adenosine metabolism and membrane transport. J Neurochem 74: 621-632.
8. Deaglio S, Dwyer KM, Gao W, Friedman D, Usheva A, Erat A, Chen JF, Enjyoji K, Linden J, Oukka M, Kuchroo VK, Strom TB, Robson SC (2007) Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 204: 1257-1265.
9. By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Fenouillet E, Guieu R, Ruf J (2010) Monoclonal antibody-assisted stimulation of adenosine A2A receptors induces simultaneous downregulation of CXCR4 and CCR5 on CD4+ T-cells. Hum Immunol 71: 1073-1076.
10. Guieu R, Sampieri F, Bechis G, Halimi G, Dussol B, Berland Y, Sampol J, Rochat H (1999) Development of an HPLC/diode array detector method for the determination of human plasma adenosine concentrations. J Liq Chromatogr 22: 1829-1841.
11. Dussol B, Fenouillet E, Brunet P, Purgus R, Sauze N, Carrega L, Mercier L, Zouher I, Bechis G, Berland Y, Guieu R (2004) Kinetic study of adenosine concentrations and the expression of adenosine deaminase in mononuclear cells during hemodialysis. Kidney Int 66: 1640-1646.
12. By Y, Durand-Gorde JM, Condo J, Lejeune PJ, Mallet B, Carayon P, Guieu R, Ruf J (2009) Production of an agonist-like monoclonal antibody to the human A2A receptor of adenosine for clinical use. Mol Immunol 46: 400-405.
13. Atkuri KR, Herzenberg LA, Niemi AK, Cowan T, Herzenberg LA (2007) Importance of culturing primary lymphocytes at physiological oxygen levels. Proc Natl Acad Sci U S A 104: 4547-4552.
14. Caldwell CC, Kojima H, Lukashev D, Armstrong J, Farber M, Apasov SG, Sitkovsky MV (2001) Differential effects of physiologically relevant hypoxic conditions on T lymphocyte development and effector functions. J Immunol 167: 6140-6149.
15. Saraste M (1999) Oxidative phosphorylation at the fin de siecle. Science 283: 1488-1493.
16. Greiner EF, Guppy M, Brand K (1994) Glucose is essential for proliferation and the glycolytic enzyme induction that provokes a transition to glycolytic energy production. J Biol Chem 269: 31484-31490.
17. O'Flaherty JT, Kreutzer DL, Showell HJ, Ward PA (1977) Influence of inhibitors of cellular function on chemotactic factor-induced neutrophil aggregation. J Immunol 119: 1751-1756.
18. Simchowitz L, Mehta J, Spilberg I (1979) Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum 22: 755-763.
19. MacDonald HR, Koch CJ (1977) Energy metabolism and T-cell-mediated cytolysis. I. Synergism between inhibitors of respiration and glycolysis. J Exp Med 146: 698-709.
20. Maeda T, Koos BJ (2009) Adenosine A1 and A2a receptors modulate insulinemia, glycemia, and lactatemia in fetal sheep. Am J Physiol Regul Integr Comp Physiol 296: R693-R701.
21. Eltzschig HK (2009) Adenosine: an old drug newly discovered. Anesthesiology 111: 904-915.
22. Morote-Garcia JC, Rosenberger P, Kuhlicke J, Eltzschig HK (2008) HIF-1-dependent repression of adenosine kinase attenuates hypoxia-induced vascular leak. Blood 111: 5571-5580.
23. Gomez G, Sitkovsky MV (2003) Differential requirement for A2a and A3 adenosine receptors for the protective effect of inosine in vivo. Blood 102: 4472-4478.
24. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P, Odegard KC, Laussen PC, Thompson LF, Colgan SP (2006) Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108: 1602-1610.
25. Huang S, Apasov S, Koshiba M, Sitkovsky M (1997) Role of A2a extracellular adenosine receptor-mediated signaling in adenosine-mediated inhibition of T-cell activation and expansion. Blood 90: 1600-1610.
26. Sitkovsky MV (2009) T regulatory cells: hypoxia-adenosinergic suppression and re-direction of the immune response. Trends Immunol 30: 102-108.
27. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV (1999) Patterns of A2A extracellular adenosine receptor expression in different functional subsets of human peripheral T cells. Flow cytometry studies with anti-A2A receptor monoclonal antibodies. Mol Pharmacol 55: 614-624.
28. Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7: 759-770.
29. Ohta A, Sitkovsky M (2001) Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage. Nature 414: 916-920.
30. Chouker A, Thiel M, Lukashev D, Ward JM, Kaufmann I, Apasov S, Sitkovsky MV, Ohta A (2008) Critical role of hypoxia and A2A adenosine receptors in liver tissue-protecting physiological anti-inflammatory pathway. Mol Med 14: 116-123.
31. Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P, Lukashev D, Bittmann I, Sitkovsky MV (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3: e174.
32. Ben-Shoshan J, Maysel-Auslender S, Mor A, Keren G, George J (2008) Hypoxia controls CD4 + CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38: 2412-2418.